However, with the significant effects of IGF1R co-targeting not observed in MET-negative Ewing sarcoma counterparts, this setting appeared unsuitable to pursue potential RON−IGF1R−MET interaction in rhabdomyosarcoma. Here, IGF1R is linked to Ewing sarcoma.